Compounded semaglutide New Jersey adults bought online during the shortage is not automatically legal today, and FDA's newest round of warning letters is the reason to check your vial. The question is not whether you broke a rule. It is whether what you inject came from a state-licensed compounding pharmacy with a named prescriber.

What Changed For Compounded Semaglutide New Jersey Buyers?

The legal basis changed underneath you. Federal law let pharmacies compound copies of an approved drug while it sat on the shortage list, and FDA marked semaglutide resolved on February 21, 2025.

So a shortage-era vial and a legal preparation today are not the same thing. What is left is narrower and turns on documentation for one individual patient. Under 503A, 503B, a 503A compounding pharmacy works on a prescription through a licensed pharmacist, a 503B outsourcing facility registers federally, and neither may prepare essentially a copy of a commercial product.

Here is the real problem. Almost nobody who ordered online knows which filled the box.

Why Did The FDA Send Another Thirty Warning Letters?

Because of marketing and hidden sourcing, not because patients misbehaved. In March 2026 FDA issued 30 warning letters to telehealth sites marketing compounded GLP-1 products, citing claims that a compounded copy is the same as the approved drug, and private labels that hide the actual compounder.

This is not new. An earlier round reached sellers directly, including one September 9, 2025 letter over semaglutide, tirzepatide and retatrutide sold as unapproved drugs.

Sit with that for a moment. If the seller will not name the pharmacy, nobody owns the quality of your dose.

What Are The Red Flags On The Vial In Your Fridge?

Four say stop and get a review before your next injection. Read the label, then read the email that came with it.

• Research-use-only wording. FDA has warned companies selling semaglutide, tirzepatide and similar peptides falsely labelled for research purposes or not for human consumption, then shipped with dosing instructions.
• No named source pharmacy. A telehealth brand is not a compounding pharmacy. The two should appear as separate entities.
• Dosing in units, not milligrams. Syringe units measure volume. Your prescription is a mass.
• No prescriber you can reach. A chat widget is not a provider.

Any one of those and you are guessing. If you aren’t testing you’re guessing.

Why Does Sloppy Sourcing Show Up As Side-Effect Roulette?

Because the variable is the vial, not your body. FDA states that unapproved GLP-1 products could contain too little, too much or no active ingredient at all, so two batches at the same mark on the syringe are not the same dose.

Unit maths makes it worse. A peer-reviewed review cites FDA’s alert on overdosing errors with compounded injectable semaglutide that led to adverse events and hospitalizations.

So what people describe is erratic rather than obviously wrong. Weeks of nothing, then a week of misery. That swing also costs lean tissue, which is why we test muscle and bone, not only weight.

What Does New Jersey Require Of A Pharmacy That Ships To Residents?

New Jersey requires registration. Under state administrative code, any pharmacy outside the state that ships, mails or delivers legend drugs into New Jersey on a prescription must register as an out-of-State pharmacy, and the Board of Pharmacy runs that application.

The delivery address is what triggers it. That rule covers a box landing at a Tinton Falls house from one of the other states. Many grey-market shippers never applied, and FDA’s counterfeit alert tells consumers to buy through state-licensed pharmacies.

Ask two questions. Which pharmacy prepared this, and is the telehealth prescribing clinician licensed here?

What Happens When You Bring Your Vial To FIT Clinic?

You get a baseline, then a decision. We are at 8 Merchants Way in Colts Neck, with FIT Clinic, FIT Lab and FIT Stretch across Colts Neck, Tinton Falls and Seabrook, so clinical review and testing happen in one place.

The review is boring on purpose. Labels, source, prescriber, dose history, body composition, strength numbers, HRV. Our first-visit testing exists so the plan is yours and not a template.

Then two options. Run it properly with a named prescriber and a licensed supply, or step off onto a strength-led program that holds the ground you gained. If cost drove you online, a denied claim can be appealed.

Frequently asked questions

FDA aims enforcement at sellers, not patients. The warning letters went to telehealth companies over how products were marketed and sourced, not to the people who ordered during a shortage. Bring the vial in anyway, because what you took belongs in your record.

No. Registration is a listing, not approval. A 503B outsourcing facility registers with the federal agency, yet no compounded drug carries FDA approval for safety, efficacy or quality. That is the distinction sameness advertising blurs, so read the phrase as sourcing, not quality.

Sometimes, on an individual clinical basis only. With the shortage resolved, a 503A pharmacy needs a prescriber documenting a patient-specific need the commercial product cannot meet. A pharmacy offering it to every customer as a cheaper copy is not working inside that exception.

Yes, every time. GLP-1 medicines slow gastric emptying, which matters before surgery, sedation and any procedure requiring an empty stomach. If your chart says nothing, the anaesthetist is planning blind. Photograph the label and the shipping email so the information travels with you.

Ask it for the New Jersey out-of-State pharmacy registration and the name of the pharmacist in charge, then verify with the state Board of Pharmacy. A legitimate operation answers in one email. Silence, or a reply naming only the telehealth brand, is your answer.

The Bottom Line

You were not reckless. You were solving a cost problem with the options available at the time, and the rules moved after you started.

So bring it in. The vial, the box, the emails, the dose history. We will take a real baseline, tell you what we can and cannot stand behind, and build the next block either on the medicine or off it. Book a review at 8 Merchants Way in Colts Neck, or call (848) 301-1515.

Call 848-301-1515 to talk about where to start.

Functionised — 8 Merchants Way, Colts Neck, NJ 07722.

Sources

• FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
• FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain
• FD&C Act Provisions that Apply to Human Drug Compounding
• Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product (FDA guidance)
• Warning Letter: GLP-1 Solution – 715883 – 09/09/2025
• Why the FDA Issued 30 Warning Letters to Telehealth Sites Marketing Compounded GLP-1s
• Semaglutide Shortage Resolved
• Frequently asked questions to the 2023 obesity medicine association position statement on compounded peptides
• N.J. Admin. Code 13:39-4.20 – Out-of-State pharmacy registration
• New Jersey Division of Consumer Affairs, Board of Pharmacy Applications